Ronald Shore

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jul 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.

Yuji Yamaguchi, Elena Peeva, Ester Del Duca

Pageof 1

Frequent Collaborators

1 joint publications

Yuji Yamaguchi

1 joint publications

Ester Del Duca

1 joint publications

Paola Facheris

1 joint publications

Jonathan Bar

1 joint publications

Abigail Sloan

1 joint publications

Diamant Thaçi

1 joint publications

Anand Ganesan

1 joint publications

George Han

1 joint publications

Khaled Ezzedine

1 joint publications

Zhan Ye

Frequent Collaborators

1 joint publications

Yuji Yamaguchi

1 joint publications

Ester Del Duca

1 joint publications

Paola Facheris

1 joint publications

Jonathan Bar

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

14.9K
See more related videos

Top Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

14.9K
See more related videos